General Cell Collection Detail

ECACC General Cell Collection: RAJI


Supplied by:	European Collection of Authenticated Cell Cultures (ECACC)
Culture Type:	Cell line
Collection:	ECACC General Collection

Catalogue No.:	85011429
Cell Line Name:	RAJI

Other Collection No.:	ATCC CCL 86
Citation Guidance:	If use of this culture results in a scientific publication, it should be cited in the publication as: RAJI (ECACC 85011429)

Keywords:	Human Burkitt's lymphoma
Cell Line Description:	Established in 1963 from Burkitt's lymphoma in an 11 year old male. Growth is in the form of single cells without attachment and as macroscopically visible clumps containing many hundreds of cells. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles. Ethnicity: Black.
Species:	Human
Tissue of Origin:	lymph

CellType:	Lymphoblastoid

Growth Mode:	Suspension
DNA Profile:	STR-PCR Data: Amelogenin: X,Y CSF1PO: 10,12 D13S317: 13 D16S539: 8,11 D5S818: 10,13 D7S820: 10 THO1: 6,7 TPOX: 8,13 vWA: 16,19
Karyotype:	2n = 46, diploid

Biosafety Information:	Unless specified otherwise, at the European Collection of Authenticated Cell Cultures (ECACC) we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines. ACDP = Advisory Committee on Dangerous Pathogens (UK) All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises. Hyperlinks to MSDS documents: Frozen cell cultures Material Safety Data Sheet Growing cell cultures Material Safety Data Sheet Nucleic acids derived from cell cultures Material Safety Data Sheet

Subculture Routine:	If starting from a frozen ampoule the cryoprotectant should be removed. Add thawed cells to a conical based centrifuge tube e.g. 15ml tube, and then slowly add 4 ml of culture medium to the tube. Take a sample of the cell suspension, e.g. 100μl, to count cells. Centrifuge the cell suspension at low speed i.e. 100 - 150 x g for a maximum of 5 minutes. Remove medium and re-suspend the cell pellet at a density of approximately 5 x 100,000 cells/ml into fresh medium containing 20% serum. Incubate flask at 37°C; 5 - 7% CO2. Check daily and keep flask in a vertical position until the cells reach the exponential phase of growth. This can take up 3-4 days. Once the culture is established the serum concentration can be reduced to 10%. Maintain cultures between 3-9x100,000 cells/ml; 5% CO2; 37°C.
Culture Medium:	RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
Depositor:	Prof H Harris/Dr R Sutherland, Sir William Dunn School of Pathology, Oxford
Originator:	No
Country:	UK
References:	Pulvertaft JV 1964 CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).Lancet. 1:238-40 PMID: 14086209; J Nat Cancer Inst 1966;37:547; Trans NY Acad Sci 1966;29:61
Additional Bibliography:	Not specified
Patents:	None specified by Depositor
Release Conditions:	No

Product Documents

Note: Links open in a new window

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.